Clinical trials
Dengue trials in Brazil
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
26 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2010 | 2 |
| 2011 | 3 |
| 2013 | 1 |
| 2014 | 1 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 1 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 12 |
| Not yet recruiting | 3 |
| Recruiting | 3 |
| Terminated | 3 |
| Unknown status | 3 |
| Active, not recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Butantan Institute | 5 |
| Sanofi Pasteur, a Sanofi Company | 5 |
| University of Heidelberg Medical Center | 3 |
| GlaxoSmithKline | 2 |
| Albert B. Sabin Vaccine Institute | 1 |
| Atea Pharmaceuticals, Inc. | 1 |
| Federal University of Minas Gerais | 1 |
| Janssen Research & Development, LLC | 1 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 1 |
| Novartis Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dengue | 26 |
| Chikungunya Fever | 5 |
| Severe Dengue | 5 |
| Zika Virus Infection | 3 |
| Hemorrhagic Fevers, Viral | 2 |
| Vector Borne Diseases | 2 |
| Acquired Immunodeficiency Syndrome | 1 |
| Arbovirus Infections | 1 |
| Fever | 1 |
| Flavivirus Infections | 1 |
Trials
Showing 26 to 26 of 26. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.